Skip to main content

Caris Taps GenoSpace to Support Oncology Service

NEW YORK (GenomeWeb) – Caris Life Science said today that it will use informatics solutions offered by GenoSpace to support its oncology profiling services.

Specifically, Caris said it will use GenoSpace's population analytics offerings to analyze data from its tumor profiling service, Caris Molecular Intelligence. Caris will also leverage GenoSpace's analytics architecture expertise to mine data in Caris Registry, its database of clinicopathologic and outcome variables collected from consenting patients.

"The combination of GenoSpace's population analytics offerings and Caris' unprecedented database and registry will provide a unique opportunity for discovery of new biomarkers that can predict a wide range of clinically relevant endpoints and ultimately lead to improvements in the quality and cost of patient care," John Quackenbush, GenoSpace's CEO, said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.